Tvardi Therapeutics
TVRD · NASDAQ
$0.992+$0.022 (+2.27%)TodayMarket closed ·
Prev close $0.97
Who owns TVRD
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 36.7% of TVRD’s shares.
- Sporos Bioventures LLC6.7%
- Solas Tvardi Sidecar LLC6.1%
- Slate Path Capital LP5.6%
- Tweardy (David John)5.2%
- Next 6 largest institutions13.0%
- All other shareholders63.3%
| Holder | Shares | % of shares |
|---|---|---|
| Sporos Bioventures LLC | 837.64K | 6.71% |
| Solas Tvardi Sidecar LLC | 761.29K | 6.10% |
| Slate Path Capital LP | 704.12K | 5.64% |
| Tweardy (David John) | 649.05K | 5.20% |
| DePinho (Ronald A) | 426.19K | 3.41% |
| Vanguard Capital Management, LLC | 344.38K | 2.76% |
| Tweardy (Samuel David) | 315.66K | 2.53% |
| American Financial Group, Inc. | 223.66K | 1.79% |
| Vifor (International), Ltd | 205.47K | 1.65% |
| UBS Financial Services, Inc. | 111.13K | 0.89% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 258.43K | 2.07% |
| Vanguard Extended Market Index Fund | 85.96K | 0.69% |
| Fidelity Extended Market Index Fund | 42.12K | 0.34% |
| Fidelity Total Market Index Fund | 14.44K | 0.12% |
| Fidelity Series Total Market Index Fund | 12.18K | 0.10% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of TVRD in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Shiff Susan Ph.D. | Award | 6.00K | — |
| HALL WALLACE L JR | Award | 6.00K | — |
| Smith Cynthia | Award | 6.00K | — |
| Shah Sujal | Award | 6.00K | — |
| WYZGA MICHAEL S | Award | 6.00K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 224.40K
- Days to cover
- 1.00
- % of shares outstanding
- 1.80%
- Average daily volume
- 296.70K
- Change since last report
- −12.2%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.